The heat shock protein-CD91 pathway: A molecular description of tumor immunosurveillance

OncoImmunology

Volumn 3, Issue 4, 2014, Pages

  Zhou, Yu Jerry ^a   Binder, Robert Julian ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CD91; Cross presentation; HSP; T cells; Tumor

Indexed keywords

CALRETICULIN; GLUCOSE REGULATED PROTEIN; GLYCOPROTEIN GP 96; GRP170 PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; ARTICLE; BINDING SITE; CARCINOGENESIS; CROSS PRESENTATION; CYTOKINE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LYMPHOCYTE FUNCTION; NONHUMAN; PROTEIN FUNCTION; RECEPTOR BINDING;

EID: 84902603019     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.28222     Document Type: Article

References (10)

1. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002; 3:991-8; PMID:12407406; http://dx.doi.org/10.1038/ni1102-991
2. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001; 410:1111-6; PMID:11323676; http://dx.doi.org/10.1038/35074129
3. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohmé I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frödin L, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995; 60:183-9; PMID:7829213; http://dx.doi.org/10.1002/ijc.2910600209
4. Kropp LE, Garg M, Binder RJ. Ovalbumin-derived precursor peptides are transferred sequentially from gp96 and calreticulin to MHC class I in the endoplasmic reticulum. J Immunol 2010; 184:5619-27; PMID:20410492; http://dx.doi.org/10.4049/jimmunol.0902368
5. Binder RJ, Srivastava PK. Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat Immunol 2005; 6:593-9; PMID:15864309; http://dx.doi.org/10.1038/ni1201
6. Li M, Davey GM, Sutherland RM, Kurts C, Lew AM, Hirst C, Carbone FR, Heath WR. Cellassociated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol 2001; 166:6099-103; PMID:11342628
7. Zhou YJ, Messmer MN, Binder RJ. Establishment of tumor-associated immunity requires interaction of Heat Shock Proteins with CD91. Cancer Immunol Res 2014; 2:217-228; http://dx.doi.org/10.1158/2326-6066.CIR-13-0132
8. Binder RJ. Heat-shock protein-based vaccines for cancer and infectious disease. Expert Rev Vaccines 2008; 7:383-93; PMID:18393608; http://dx.doi.org/10.1586/14760584.7.3.383
9. Pawaria S, Binder RJ. CD91-dependent programming of T-helper cell responses following heat shock protein immunization. Nat Commun 2011; 2:521; PMID:22045000; http://dx.doi.org/10.1038/ncomms1524
10. Messmer MN, Pasmowitz J, Kropp LE, Watkins SC, Binder RJ. Identification of the cellular sentinels for native immunogenic heat shock proteins in vivo. J Immunol 2013; 191:4456-65; PMID:24048898; http://dx.doi.org/10.4049/jimmunol.1300827